Prevention's Price–30-Day Outcomes of Risk-Reducing Mastectomy and Immediate Free Flap Breast Reconstruction
Clinical Breast Cancer · 2025
DOI: 10.1016/j.clbc.2025.07.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Samuel Knoedler und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT. Hauptthemen laut MEDLINE: Mammaplasty, Breast Neoplasms, Free Tissue Flaps, Postoperative Complications. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Risk-reducing mastectomy (RRM) with free flap breast reconstruction (FFBR) is increasingly utilized for breast cancer prevention. While its oncological benefits are well-established, data on perioperative safety remain limited. To address this gap, we analyzed postoperative outcomes and risk factors for complications utilizing the American college of surgeons national surgical quality improvement program (ACS-NSQIP) database. METHODS: The American college of surgeons national surgical quality improvement program (ACS-NSQIP) (2008-2022) database was queried to identify adult female patients who underwent RRM-FFBR. Primary outcomes included 30-day rates of reoperation, readmission, and surgical or medical complications. Confounder-adjusted multivariate logistic regression was used to identify factors associated with postoperative complications. RESULTS: A total of 985 patients were included, with a mean age and BMI of 46 ± 9.4 years and 31 ± 5.7 kg/m², respectively. The most common comorbidities were obesity (n = 492; 50%) and hypertension (n = 170; 17%). Complications occurred in 171 (17%) cases, with 134 (14%) reoperations and 69 (7.0%) readmissions. 125 (13%) surgical complications were recorded, the majority of which were bleeding events (n = 105; 11%). Medical complications were rare (n = 33; 3.4%). Multivariable analyses revealed that higher hypertension (OR 1.8; 95% CI, 1.1-2.8; P = .017) and diabetes (OR 2.2.; 95% CI, 1.1-4.6; P = .031) were significantly associated with the occurrence of postoperative complications. CONCLUSION: This multi-institutional study revealed 30-day complication and reoperation rates of 17% and 14%, respectively, following RRM-FFBR. Hypertension and diabetes were significant predictors of postoperative morbidity. Preoperative optimization of these modifiable risk factors may help improve surgical outcomes. These findings underscore the importance of individualized patient management and informed decision-making in RRM-FFBR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Plastic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT.
- Division of Plastic Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT; Department of Hand-, Plastic, and Reconstructive Surgery, Microsurgery, Burn Trauma Center. BG Trauma Center Ludwigshafen, Univ…
- Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Hand-, Plastic, and Reconstructive Surgery, Microsurgery, Burn Trauma Center. BG Trauma Center Ludwigshafen, University of Heidelberg, Ludwigshafen, Germany.
- Department of Plastic, Reconstructive, and Aesthetic Surgery, Padova University Hospital, Padua, Italy; Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation, Cleveland, OH.
- Department of Plastic, Reconstructive, and Aesthetic Surgery, Padova University Hospital, Padua, Italy.
Zitieren
APA
Knoedler, S., Diatta, F., Hu, K., Klimitz, F., Wirtz, J. M., Schaschinger, T., Perozzo, F. A. G., Sofo, G., Marena, F., Kim, B. S., Pomahac, B., & Kauke-Navarro, M. (2025). Prevention's Price–30-Day Outcomes of Risk-Reducing Mastectomy and Immediate Free Flap Breast Reconstruction. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.07.003
Vancouver
Knoedler S, Diatta F, Hu K, Klimitz F, Wirtz JM, Schaschinger T, et al. Prevention's Price–30-Day Outcomes of Risk-Reducing Mastectomy and Immediate Free Flap Breast Reconstruction. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.07.003
BibTeX
@article{Knoedler2025,
author = {Knoedler, Samuel and Diatta, Fortunay and Hu, Kevin and Klimitz, Felix and Wirtz, Julius M and Schaschinger, Thomas and Perozzo, Filippo A G and Sofo, Giuseppe and Marena, Francesco and Kim, Bong-Sung and Pomahac, Bohdan and Kauke-Navarro, Martin},
title = {Prevention's Price–30-Day Outcomes of Risk-Reducing Mastectomy and Immediate Free Flap Breast Reconstruction},
journal = {Clinical Breast Cancer},
year = {2025},
doi = {10.1016/j.clbc.2025.07.003}
}
EUVIMED